Thursday, September 22, 2016

BRIEF-CTi biopharma granted 180 day extension by NASDAQ to regain compliance

* CTi Biopharma granted 180 day extension by NASDAQ to

regain compliance with minimum bid price rule

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)